Loading stock data…

© 2026 Whystock · Bureau7 LLC. Intelligent Financial Insights.

Not financial advice. Data may be delayed. Use at your own risk.

Stock Glossary Popular Stocks Stock ScreenerPrivacy Terms

Why INAB? IN8bio, Inc. Analysis, Price & AI Insights | Whystock

INAB

$1.50+0.03 (+2.04%)

Market ClosedLast close May 1

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO

Intraday

Custom Range:

to

No data available for this range. Intraday data may be limited by the exchange.